Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics
|Affiliates||Rituparna Bhattacharya , Raymond A Harvey , Keli Abraham , Jon Rosen , Paul Mehta 
 Humana Inc.
|Journal||Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration|
|Summary||This study estimates ALS prevalence and survival in participants with Medicare. The 5-year period prevalence was 20.5 per 100,000. The 2011-point prevalence for ALS was 11.8 per 100,000. Analyses using Medicare data resulted in higher ALS prevalence estimates than previously reported.|
|Link tp paper||Find the paper hereexternal icon!|